Notice_of_Intent_1.pdf

PDF 155 KB Posted

Attached to
NICHD: Service: PacBio Sequel II Service Agreement
Solicitation number
75N94025Q00031
Issued by

About this file

This is a Notice of Intent to Sole Source for solicitation number 75N94025Q00031 issued by the National Institute of Child Health and Human Development (NICHD) for a PacBio Sequel II Service Agreement. The agency intends to award a noncompetitive sole source purchase order to Pacific Biosciences of California to provide maintenance services for two PacBio Sequel II sequencers used in the NICHD's Molecular Genomics Core facility.

The period of performance is January 11, 2025 through January 10, 2026 with three one-year options through January 10, 2029. The service agreement includes parts, labor, consumables, remote support, software updates, reagents for troubleshooting, real-time monitoring, remote diagnostics, and priority on-site response. The NAICS code is 811210 with a $34 million size standard. Pacific Biosciences is identified as the sole source due to their exclusive patents and ability to provide services and reagents for their proprietary sequencing technology. Interested parties must respond by December 27, 2024 at 12:00 PM ET to nicole.freid@nih.gov with capabilities statements including pricing, delivery terms, and business size certification.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Notice of Intent to Sole Source

Solicitation Number: 75N94025Q00031 Solicitation Type: Sole Source (Non‐Competitive) Title: NICHD: Service: PacBio Sequel II Service Agreement NAICS / Size Standard: 811210/ 34 Million

Introduction

THIS IS A PRE‐SOLICITATION NON‐COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION. The National Institute of Child Health and Human Development (NICHD), Office of Acquisitions (OA), intends to negotiate and award a purchase order on a noncompetitive sole source basis to small business Pacific Biosciences of California to provide a PacBio Sequel II Service Agreement to the NICHD.

Background Information

The PacBioSequel II is a sophisticated machine that is used by Molecular Genomics Core that provides service for all NICHD researchers. Preventive maintenance assures consistent, accurate results, minimizing downtime and costly equipment repairs.

Purpose and Objectives

A service contract is needed to maintain two sequencers that constitute the core of our facility operation.

Service from the manufacturer ensures that qualified experts perform maintenance, thus maximizing the equipment’s longevity and minimizing the risk of data loss.

Period of Performance

The Period of Performance will be January 11, 2025 through January 10, 2026 with the potential for three option years as follows:

Option Year 1: January 11, 2026 through January 10, 2027 Option Year 2: January 11, 2027 through January 10, 2028 Option Year 3: January 11, 2028 through January 10, 2029

Contractor Requirements

The contractor shall provide the service agreement that meets the following specifications:

Comp Sequel II service contract, w insight‐1 year of Sequel II or IIe system parts, labor, and consumables required for repair and planned maintenance with remote support enabled.

Remote support included are software updates, reagents for troubleshooting, real‐time performance monitoring, remote diagnostics.

Priority on‐site response, and email and phone response.

Subject to PacBio Terms and Conditions and applicable Service Contract Data Sheet.

Sole Source Justification

Pacific Biosciences is the sole service provider on their equipment. This is highly sophisticated machine that requires specifically trained field service technician for maintenance and repair. This service agreement also includes replacement of PacBio reagents in case of hardware or operational failure.

PacBio Inc is the only company that can provide the reagents and service contracts for the PacBio, Sequell IIe. Due to its sophistication, only PacBio can provide servicing solutions to their instruments.

The PacBio, Sequell IIe long read sequencing technology offers deep and broad coverage through advanced applications for a comprehensive view of the genome. The system relies on patents owned by or licensed to PacBio covering the instrument, sequencing chips, and sequencing reagents. The reagent kits and service contracts are exclusively provided by PacBio.

Regulatory Authority

This acquisition is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart 13.106‐1(b) Soliciting from a single source. (1) For purchases not exceeding the simplified acquisition threshold, contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, or industrial mobilization).

FAR Clauses

The provision at FAR clause 52.212‐1, Instructions to Offerors – Commercial Items, applies to this acquisition.

The provision at FAR clause 52.212‐2, Evaluation – Commercial Items, is applicable. The Government will award a contract resulting from this notice to the offeror listed above. The following factors shall be used to evaluate the offer: The contractor shall demonstrate its ability to provide the detector listed that meets the specifications provided above.

FAR clause 52.212‐3, Offeror Representations and Certifications – Commercial Products and Commercial Services, is applicable. The Offeror shall complete only paragraph (b) of this provision if the Offeror has completed the annual representations and certification electronically in the System for Award Management (SAM) accessed through https://www.sam.gov. If the Offeror has not completed the annual representations and certifications electronically, the Offeror shall complete only paragraphs (c) through

(v) of this provision.

FAR clause at 52.212‐4, Contract Terms and Conditions – Commercial Products and Commercial Services applies to this acquisition.

FAR clause at 52.212‐5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders – Commercial Products and Commercial Services applies to this acquisition.

FAR 52.217‐9, Option to Extend the Term of the Contract, is applicable to this award as follows:

(a) The Government may extend the term of this contract by written notice to the Contractor within the term of this contract; provided that the Government gives the Contractor a preliminary written notice of its intent to extend at least 10 days prior to contract expiration. The preliminary notice does not commit the Government to an extension.

(b) If the Government exercises this option, the extended contract shall be considered to include this option clause.

(c) The total duration of this contract, including the exercise of any options under this clause, shall not exceed four (4) years.

Additional Information

The North American Industry Classification System (NAICS) Code is 811210 and the Small Business Size Standard is 34 Million. This acquisition is being conducted under FAR Part 13, Simplified Acquisition Procedures, therefore the requirements of FAR Part 6, Competitive Requirements, are not applicable and the resultant award will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 2025‐02 effective November 12, 2024.

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties’ bona‐fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Unique Entity Identifier (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non‐competitive basis or to conduct a competitive procurement.

All responses must be received by December 27, 2024 12:00 PM ET and must reference solicitation number 75N9402512Q00031. Responses shall be submitted electronically to nicole.freid@nih.gov.

Responses will only be accepted if dated and signed by an authorized company representative. All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.

File details come from the government source that posted it. Updated .